Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 399   Home Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1Assessment of the Respiratory Tract Distribution of Fluorescein by Nebulization in Rats (Rattus norvegicus)
Isabelle Desprez,Charlotte Boyer,Jean-Luc Servely,Audrey Carlet-Lejallé,Edouard Reyes-Gomez,Thomas M. Donnelly,Charly Pignon
Journal of Exotic Pet Medicine.2019;30()30
[DOI]
2Spray freeze drying: Emerging applications in drug delivery
D.A. Vishali,J. Monisha,S.K. Sivakamasundari,J.A. Moses,C. Anandharamakrishnan
Journal of Controlled Release.2019;300()93
[DOI]
3Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Kaksha Sankhe,Tabassum Khan,Chintan Bhavsar,Munira Momin,Abdelwahab Omri
Expert Opinion on Drug Delivery.2019;16(5)525
[DOI]
4Chitosan-coated nanoparticles enhanced lung pharmacokinetic profile of voriconazole upon pulmonary delivery in mice
Paramita Paul,Soma Sengupta,Biswajit Mukherjee,Tapan K Shaw,Raghuvir H Gaonkar,Mita Chatterjee Debnath
Nanomedicine.2018;13(5)501
[DOI]
5Biodegradable micro-sized discoidal polymeric particles for lung-targeted delivery system
Jun Young Park,Sanghyo Park,Tae Sup Lee,Yong Hwa Hwang,Jung Young Kim,Won Jun Kang,Jaehong Key
Biomaterials.2019;218(5)119331
[DOI]
6Patented therapeutic drug delivery strategies for targeting pulmonary diseases
Ajay Kumar Thakur,Dinesh Kumar Chellappan,Kamal Dua,Meenu Mehta,Saurabh Satija,Inderbir Singh
Expert Opinion on Therapeutic Patents.2020;30(5)375
[DOI]
7Patented therapeutic drug delivery strategies for targeting pulmonary diseases
Thundiparambil Azeez Sonia,Chandra P. Sharma
Expert Opinion on Therapeutic Patents.2014;30(5)59
[DOI]
8Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates
Blessing Aderibigbe,Isiaka Aderibigbe,Patricia Popoola
Pharmaceutics.2016;9(4)2
[DOI]
9Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery
Rajiv Bajracharya,Jae Geun Song,Seung Yun Back,Hyo-Kyung Han
Computational and Structural Biotechnology Journal.2019;17(4)1290
[DOI]
10Drug delivery applications of chitin and chitosan: a review
Rabinarayan Parhi
Environmental Chemistry Letters.2020;18(3)577
[DOI]
11Carrier optimization of pulmonary powder systems with using computational intelligence tools
Adam Paclawski,Jakub Szlek,Thi Quynh Ngoc Nguyen,Raymond Lau,Renata Jachowicz,Aleksander Mendyk
Powder Technology.2018;329(3)76
[DOI]
12The use of fatty acids as absorption enhancer for pulmonary drug delivery
Maliheh Ghadiri,Finbarr Canney,Cristina Pacciana,Gaia Colombo,Paul M. Young,Daniela Traini
International Journal of Pharmaceutics.2018;541(1-2)93
[DOI]
13Challenges and innovations of drug delivery in older age
Muhammad Suleman Khan,Michael S. Roberts
Advanced Drug Delivery Reviews.2018;135(1-2)3
[DOI]
14Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation
Homa Faghihi,Abdolhossein Rouholamini Najafabadi,Zahra Daman,Elham Ghasemian,Hamed Montazeri,Alireza Vatanara
AAPS PharmSciTech.2019;20(3)3
[DOI]
15Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation
Prem Prakash Sharma,Anshu Sharma,Pratima R. Solanki
AAPS PharmSciTech.2016;79(3)365
[DOI]
16Evaluation of highly branched cyclic dextrin in inhalable particles of combined antibiotics for the pulmonary delivery of anti-tuberculosis drugs
Kazunori Kadota,Arisa Senda,Hideaki Tagishi,John Oluwasogo Ayorinde,Yuichi Tozuka
International Journal of Pharmaceutics.2017;517(1-2)8
[DOI]
17Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung
A. Nieto-Orellana,H. Li,R. Rosiere,N. Wauthoz,H. Williams,C.J. Monteiro,C. Bosquillon,N. Childerhouse,G. Keegan,D. Coghlan,G. Mantovani,S. Stolnik
Journal of Controlled Release.2019;316(1-2)250
[DOI]
18Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung
Vinod Kumar Khanna
Journal of Controlled Release.2016;316(1-2)409
[DOI]
19Evolution of the scientific literature on drug delivery: A 1974–2015 bibliometric study
C. Robert,C.S. Wilson,A. Venuta,M. Ferrari,C.-D. Arreto
Journal of Controlled Release.2017;260(1-2)226
[DOI]
20Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation
Rachel Yoon Kyung Chang,Ke Chen,Jiping Wang,Martin Wallin,Warwick Britton,Sandra Morales,Elizabeth Kutter,Jian Li,Hak-Kim Chan
Antimicrobial Agents and Chemotherapy.2017;62(2)226
[DOI]
21Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation
Sally Yunsun Kim,Wojciech Chrzanowski
Antimicrobial Agents and Chemotherapy.2019;62(2)241
[DOI]
22Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
Duo Zhang,Heedoo Lee,Xiaoyun Wang,Ashish Rai,Michael Groot,Yang Jin
Molecular Therapy.2018;26(9)2119
[DOI]
23Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
Rabinarayan Parhi
Molecular Therapy.2019;36(9)175
[DOI]
24Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids
Elisa A. Torrico Guzmán,Qihua Sun,Samantha A. Meenach
ACS Biomaterials Science & Engineering.2019;5(12)6570
[DOI]
25Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension
Ali Keshavarz,Hossam Kadry,Ahmed Alobaida,Fakhrul Ahsan
Expert Opinion on Drug Delivery.2020;17(4)439
[DOI]
26Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension
Rohitas Deshmukh,Nabamita Bandyopadhyay,Sara Nidal Abed,Shantanu Bandopadhyay,Yogendra Pal,Pran Kishore Deb
Expert Opinion on Drug Delivery.2020;17(4)85
[DOI]
27CFD modelling of air and particle flows in different airway models
Y.H. Kim,Z.B. Tong,H.K. Chan,R.Y. Yang
Journal of Aerosol Science.2019;134(4)14
[DOI]
28Exendin-4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant
Michelle Khai Khun Yap,Nurhamimah Misuan
Basic & Clinical Pharmacology & Toxicology.2019;124(5)513
[DOI]
29Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis
María Moreno-Sastre,Marta Pastor,Amaia Esquisabel,Eulàlia Sans,Miguel Viñas,Aarne Fleischer,Esther Palomino,Daniel Bachiller,José Luis Pedraz
International Journal of Pharmaceutics.2016;498(1-2)263
[DOI]
30Supercritical CO2-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation
Marta Silva,Ana Silva,Javier Fernandez-Lodeiro,Teresa Casimiro,Carlos Lodeiro,Ana Aguiar-Ricardo
Materials.2017;10(1)74
[DOI]
31Supercritical CO2-Assisted Spray Drying of Strawberry-Like Gold-Coated Magnetite Nanocomposites in Chitosan Powders for Inhalation
Xiuwen Guan,Weifen Zhang
Materials.2020;10(1)74
[DOI]
32In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug
Ebtsam M. Abdou,Soha M. Kandil,Amany Morsi,Maysa W. Sleem
Drug Delivery.2019;26(1)689
[DOI]
33siRNA Delivery to the lung: What's new?
Olivia M. Merkel,Israel Rubinstein,Thomas Kissel
Advanced Drug Delivery Reviews.2014;75(1)112
[DOI]
34In vitro/in vivoevaluation of agarnanospheres forpulmonarydelivery of bupropion HCl
Jaleh Varshosaz,Mohsen Minaiyan,Mohammad Reza Zaki,Milad Fathi,Hossein Jaleh
Drug Delivery.2015;75(1)1
[DOI]
35In vitro/in vivoevaluation of agarnanospheres forpulmonarydelivery of bupropion HCl
Nishan K. Shah,Elisa A. Torrico Guzmán,Zimeng Wang,Samantha A. Meenach
Drug Delivery.2020;75(1)67
[DOI]
36Thermosensitive polysaccharide particles for pulmonary drug delivery
Takumi Sato,Taku Takami,Hiromu Saito,Yoshihiko Murakami
Colloids and Surfaces A: Physicochemical and Engineering Aspects.2019;580(1)123720
[DOI]
37Thermosensitive polysaccharide particles for pulmonary drug delivery
M.N. Lavanya,M. Maria Leena,J.A. Moses,C. Anandharamakrishnan
Colloids and Surfaces A: Physicochemical and Engineering Aspects.2020;580(1)123720
[DOI]
38Albumin nanocarriers for pulmonary drug delivery: An attractive approach
Monica Joshi,Mangal Nagarsenkar,Bala Prabhakar
Journal of Drug Delivery Science and Technology.2020;56(1)101529
[DOI]
39Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery
A. Sofia Silva,Ana M. Sousa,Renato P. Cabral,Marta C. Silva,Clarinda Costa,Sónia P. Miguel,Vasco D.B. Bonifácio,Teresa Casimiro,Ilídio J. Correia,Ana Aguiar-Ricardo
International Journal of Pharmaceutics.2017;519(1-2)240
[DOI]
40Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases
Dinesh Kumar Chellappan,Quinnie Ling Sze Ning,Sandra Khoo Su Min,Saw Yan Bin,Pang Jia Chern,Tan Pei Shi,Sylvia Wong Ee Mei,Tan Hui Yee,Ong Jing Qi,Lakshmi Thangavelu,S. Rajeshkumar,Poonam Negi,Jestin Chellian,Ridhima Wadhwa,Gaurav Gupta,Trudi Collet,Philip M. Hansbro,Kamal Dua
Chemico-Biological Interactions.2019;310(1-2)108732
[DOI]
41Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity
Rania A.H. Ishak,Rihab Osman
International Journal of Pharmaceutics.2015;485(1-2)249
[DOI]
42The advantages of pulmonary delivery of therapeutic siRNA
Daniel P Feldmann,Olivia M Merkel
Therapeutic Delivery.2015;6(4)407
[DOI]
43Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery
Sha Liu,Alan B. Watts,Ju Du,Amanda Bui,Soraya Hengsawas,Jay I. Peters,Robert O. Williams
European Journal of Pharmaceutics and Biopharmaceutics.2015;96(4)132
[DOI]
44Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil
Thi-Tram Nguyen,Eun-Jin Yi,Kyu-Mok Hwang,Cheol-Hee Cho,Chun-Woong Park,Ju-Young Kim,Yun-Seok Rhee,Eun-Seok Park
Drug Delivery and Translational Research.2019;9(1)319
[DOI]
45Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil
Manisha Lalan,Hemal Tandel,Rohan Lalani,Vivek Patel,Ambikanandan Misra
Drug Delivery and Translational Research.2019;9(1)291
[DOI]
46Characterization of matrix embedded formulations for combination spray-dried particles comprising pyrazinamide and rifampicin
Jun Yee Tse,Kazunori Kadota,Yoshiyuki Hirata,Masahiko Taniguchi,Hiromasa Uchiyama,Yuichi Tozuka
Journal of Drug Delivery Science and Technology.2018;48(1)137
[DOI]
47Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications
Alberto Hidalgo,Antonio Cruz,Jesús Pérez-Gil
Biochimica et Biophysica Acta (BBA) - Biomembranes.2017;1859(9)1740
[DOI]
48Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications
V.N. Pandey,Neha Tiwari,V.S. Pandey,Anita Rao,Ishwar Das
Biochimica et Biophysica Acta (BBA) - Biomembranes.2019;1859(9)437
[DOI]
49Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery
Bhuvaneshwar Vaidya,Vivek Gupta
Journal of Controlled Release.2015;211(9)118
[DOI]
50Optimization of CFTR-mRNA transfection in human nasal epithelial cells
Elena Fernández Fernández,Nadine Bangel-Ruland,Katja Tomczak,Wolf-Michael Weber
Translational Medicine Communications.2016;1(1)118
[DOI]
51Optimization of CFTR-mRNA transfection in human nasal epithelial cells
Gordon T. Bolger
Translational Medicine Communications.2018;1(1)118
[DOI]
52Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis
Tejal Rawal,Rajesh Parmar,Rajeev K. Tyagi,Shital Butani
Colloids and Surfaces B: Biointerfaces.2017;154(1)321
[DOI]
53Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of e-poly-L-lysine capped mesoporous silica-based nanoparticles
Nadya Velikova,Nuria Mas,Laura Miguel-Romero,Lorena Polo,Ellen Stolte,Edoardo Zaccaria,Rui Cao,Nico Taverne,José Ramón Murguía,Ramon Martinez-Manez,Alberto Marina,Jerry Wells
Nanomedicine: Nanotechnology, Biology and Medicine.2017;13(2)569
[DOI]
54Challenges of Curcumin Bioavailability: Novel Aerosol Remedies
Parasuraman Aiya Subramani,Venkata R. Narala
Natural Product Communications.2013;8(1)1934578X1300800
[DOI]
55Dry powder inhalation of siRNA
Tobias WM Keil,Olivia M Merkel
Therapeutic Delivery.2019;10(5)265
[DOI]
56Encapsulated Carbenoxolone Reduces Lung Metastases
Adi Karsch-Bluman,Shimrit Avraham,Miri Assayag,Ouri Schwob,Ofra Benny
Cancers.2019;11(9)1383
[DOI]
57Encapsulated Carbenoxolone Reduces Lung Metastases
Arni Ariani,Soegijardjo Soegijoko,Hermawan Rasyid
Cancers.2015;11(9)333
[DOI]
58Physical stability of dry powder inhaler formulations
Nivedita Shetty,David Cipolla,Heejun Park,Qi Tony Zhou
Expert Opinion on Drug Delivery.2020;17(1)77
[DOI]
59Processing design space is critical for voriconazole nanoaggregates for dry powder inhalation produced by thin film freezing
Chaeho Moon,Sawittree Sahakijpijarn,John J. Koleng,Robert O. Williams
Journal of Drug Delivery Science and Technology.2019;54(1)101295
[DOI]
60Processing design space is critical for voriconazole nanoaggregates for dry powder inhalation produced by thin film freezing
Suprio R. Paul,Suraj K. Nayak,Arfat Anis,Kunal Pal
Journal of Drug Delivery Science and Technology.2018;54(1)247
[DOI]
61Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy
Fatemeh Mottaghitalab,Melika Kiani,Mehdi Farokhi,Subhas C. Kundu,Rui L. Reis,Mahdi Gholami,Hassan Bardania,Rassoul Dinarvand,Parham Geramifar,Davood Beiki,Fatemeh Atyabi
ACS Applied Materials & Interfaces.2017;9(37)31600
[DOI]
62Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant
Alejandra Cimato,Graciela Facorro,Margarita Martínez Sarrasague
Respiratory Physiology & Neurobiology.2018;247(37)80
[DOI]
63Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant
Tarek A. Ahmed,Khalid M. El-Say,Osama A.A. Ahmed,Ahmed S. Zidan
Respiratory Physiology & Neurobiology.2018;247(37)335
[DOI]
64Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant
Ralph Tripp,Jarod Hanson
Respiratory Physiology & Neurobiology.2016;247(37)93
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal